News

Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Sentien Biotechnologies Names Richard Ganz as Executive Chairman

Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Sentien Biotechnologies Names Richard Ganz as Executive Chairman

LEXINGTON, MA – Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, today announced the appointment of Richard Ganz as Executive Chairman.  Mr. Ganz will continue to lead Sentien’s Board of Directors, a role he has filled for the past nine years, as well as work closely with CEO Brian Miller and Sentien’s management team. Read More >

By
In News
Posted

Sentien to Present SBI-101 Clinical Data in AKI at 2020 ASGCT Annual Meeting that Supports Expansion to COVID-19

Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Sentien to Present SBI-101 Clinical Data in AKI at 2020 American Society of Gene & Cell Therapy Annual Meeting that Supports Expansion to COVID-19

Sentien’s R&D team will present platform development and clinical data at the American Society of Gene & Cell Therapy Annual Meeting during virtual poster sessions.

Sentien’s SBI-101 clinical data in AKI patients shows immunomodulatory effects consistent with our therapeutic hypothesis and also applicable to COVID-19 patients.

Clinical Evidence for Immune Reprogramming with Extracorporeal Mesenchymal Stromal Cell Therapy

Ex-Vivo Cell Therapy Platform for Immune Reprogramming in Autoimmunity

Sentien VP of Operations Dr. Chris Gemmiti to speak at Phacilitate Leaders World & World Stem Cell Summit

Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Sentien VP of Operations Dr. Chris Gemmiti to speak at Phacilitate Leaders World & World Stem Cell Summit

On Jan 23rd at 1:50pm, Sentien VP of Operations Dr. Chris Gemmiti will be speaking about Sentien’s ex vivo allogeneic MSC therapy for the treatment of systemic, immune-mediated inflammation.

Sentien Co-Founder Dr. Biju Parekkadan to Speak at Cellular Therapeutics in Trauma and Critical Care Conference

Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Sentien Co-Founder Dr. Biju Parekkadan to Speak at Cellular Therapeutics in Trauma and Critical Care Conference

Sentien Biotechnologies Scientific Co-Founder, Dr. Biju Parekkadan, will be speaking at the Cellular Therapeutics in Trauma and Critical Care conference on 12/13 at 4:05pm.  He will be discussing ex vivo MSC therapy for the treatment of systemic inflammatory disease.

Sentien Executives Dr. Chris Gemmiti and Dr. Rita Barcia to Speak at Cell & Gene Therapy Bioprocessing & Commercialization conference

Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Sentien Executives Dr. Chris Gemmiti and Dr. Rita Barcia to Speak at Cell & Gene Therapy Bioprocessing & Commercialization Conference

Dr. Chris Gemmiti, VP Operations at Sentien, will be speaking on an Outsourcing vs. Insourcing panel on September 10, 2019.

Dr. Rita Barcia, Executive Director of R&D at Sentien, will be speaking on a Next Generation Therapies panel on September 12, 2019.

Sentien Co-Founder Dr. Biju Parekkadan to Speak at American Society of Gene & Cell Therapy Annual Meeting on 4/29

Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Sentien Co-Founder Dr. Biju Parekkadan to Speak at American Society of Gene & Cell Therapy Annual Meeting on 4/29

Sentien Biotechnologies Scientific Co-Founder, Dr. Biju Parekkadan, will be speaking at the American Society of Gene & Cell Therapy Annual Meeting on April 29, 2019 in Washington, DC.  He will be discussing Reprogramming Human Immune Responses Using Ex Vivo MSC Bioreactor Therapy.

Load More